Stocktoria
Rezolute, Inc. RZLT
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2011-12-23
Rezolute, Inc. statistics & valuation
Market cap$485.3M
P / B3.0×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -42.4% | -51.6% | -41.9% | -26.9% | -49.1% |
| Return on equity | -45.9% | -56.6% | -44.6% | -27.5% | -80.1% |
| Debt / equity | — | — | — | — | 0.54× |
| Current ratio | 14.37 | 13.39 | 20.18 | 61.78 | 21.34 |
Source: SEC EDGAR filings · CIK 0001509261 · as of 2025-06-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.